Glycogen storage disease type V
Glycogen storage disease type V, also known as McArdle disease, is a metabolic disorder characterized by a deficiency of the enzyme myophosphorylase, which impairs the body's ability to break down glycogen in muscles, leading to symptoms such as fatigue, cramps, and muscle pain. This rare condition occurs in about one in 100,000 individuals.
Health Outcomes
- Enhanced Glycogen Storage
- Enhanced Strength
- Healthy Age-Appropriate Growth
- Improved Anaerobic Performance
- Improved Anaerobic Power
- Improved Anaerobic Running Capacity
- Improved Anaerobic Threshold
- Improved Carbohydrate Oxidation
- Improved Chest Press Strength
- Improved Glycogen Synthetase Activity
- Improved Growth and Economic Traits
- Improved Isometric Maximal Voluntary Contraction Torque
- Improved Maximal Voluntary Contraction
- Improved Maximal Voluntary Isometric Contraction
- Improved Maximal Voluntary Isometric Contraction Torque
- Improved Mitochondrial Efficiency
- Improved Muscle Recovery
- Improved Power Relative to Body Mass
- Improved Push-up Performance
- Improved Repeated Sprint Ability
- Improved Skeletal Muscle Damage
- Improved Skeletal Muscle Function
- Improved Strength and Power Performance
- Improved Total Load Lifted
- Improved Wingate Anaerobic Power
- Increased Blood Lactate Response
- Increased Fat Oxidation
- Increased Fat Utilization
- Increased Hepatic Glycogen Storage
- Increased Time to Exhaustion
- Maintained Metabolic Homeostasis
- No Improvement in Growth Performance
- Reduced Anaerobic Lactic Energy
- Reduced Anaerobic Participation
- Reduced Blood Lactate
- Reduced Carbohydrate Oxidation
- Reduced Enzyme Activity
- Reduced Exercise Metabolic Intensity
- Reduced Fatigue During Sprint Repeat Task
- Reduced Lactic Acid Level
- Reduced Low-Frequency Fatigue
- Reduced Muscle Symptom
- Reduced Muscle Weakness
- Regulated Carbohydrate Metabolism Enzyme Level